Baird Medical Investment Holdings Limited BDMDW
Annual
Quarterly
FY2025 · ended Dec 31, 2025 · Revenue $22.54M, -39.2% YoY · Filed Jul 27, 2026
Baird Medical Investment Holdings Limited (BDMD) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $22.5 million and a net loss of $27.3 million. Free cash flow was -$1.4 million. As of Dec 31, 2025 it held $178,321 in cash and investments and $8.9 million in total debt.
Revenue
$22.54M
-39.2% vs prior year
Net income
$-27.28M
Operating cash flow
$-1.34M
+78.7% vs prior year
Free cash flow
$-1.39M
+84.9% vs prior year
EPS
$-0.98
-271.9% vs prior year
Dividend per share
None
Shares outstanding
40.98M
+14.7% vs prior year
Net cash
$-8.69M
FY 2025
Operating margin
-113.7%
FY 2025
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BDMD (Nasdaq), BDMDW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Sheung Wan
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1982444
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
|---|---|---|
| Revenue | $22.5M | $37.0M |
| Operating income | -$25.6M | $15.3M |
| Net income | -$27.3M | — |
| Diluted EPS | -$0.98 | $0.57 |
| Operating cash flow | -$1.3M | -$6.3M |
| Free cash flow | -$1.4M | -$9.2M |
| Total assets | $69.7M | $78.0M |
| Total liabilities | $38.5M | $38.2M |
| Stockholders' equity | $31.4M | $39.7M |
| Cash and investments | $178,321 | $3.0M |
| Total debt | $8.9M | $4.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 5, 2026 | Nov 5, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 3, 2026 | Sep 3, 2026 |
| 20-F/A | Amended annual report (foreign issuer) | Jul 27, 2026 | Dec 31, 2025 |
| 20-F | Annual report (foreign issuer) | Apr 24, 2026 | Dec 31, 2025 |
All 82 Baird Medical Investment Holdings Limited SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.